TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
FULC

Fulcrum Therapeutics Inc

Healthcare · Biotechnology

3.70$ -1.2% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Fulcrum Therapeutics Inc (FULC) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 324 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet FULC
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
279 258 233 294 279 261 243 229 215 366 347 324
262 242 218 280 267 250 233 219 206 357 339 323
30 26 40 87 73 58 42 43 47 198 50 48
257 236 213 274 257 241 227 214 201 352 333 319
1.7 2.2 1.1 3.5 3.7 3.3 2.5 1.3 0.9 1.1 1.8 2.0
-1.1 – – – – – – – – – – –
23 23 19 20 22 18 14 14 16 17 13 13
14 14 11 13 15 11 8.1 9.0 12 13 9.9 10
2.4 2.2 2.0 2.1 2.1 2.2 2.2 2.3 2.3 2.4 2.5 2.5
3.6 2.8 3.9 3.6 4.0 1.2 1.5 1.8 2.9 1.6 2.5 3.4
255 235 214 274 257 243 228 214 198 349 333 311
-485 -510 -537 -481 -503 -519 -537 -554 -574 -594 -613 -639
62 62 62 64 62 54 62 63 63 63 76 76

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?